This work was conducted in Medical School, University of São Paulo, Ribeirão Preto, Brazil
Childhood-onset systemic lupus erythematosus (c-SLE) is a chronic autoimmune disease which increases cardiovascular risk factors (CRF) such as elevated homocysteine, TNF-α, and hs-C reactive protein.
We evaluated BMI, waist circumference (WC), 24-h recalls, SLEDAI-2 K, SLICC/ACR-DI, serum levels of homocysteine, folate, TNF-α, hs-C reactive protein, lipid profile, proteomic data, and duration of corticosteroid therapy in 19 c-SLE and 38 healthy volunteers. Physiological and anthropometric variables of c-SLE and healthy controls were compared by ANCOVA. k-cluster was used to separate c-SLE into two different groups with the best and the worst metabolic profile according to previous analysis showing some metabolites that were statistically different from controls, such as homocysteine, TNF-α, hs-CRP and folate levels. These two clusters were again compared with the control group regarding nutritional parameters, lipid profile and also proteomic data.
Individuals with c-SLE presented higher BMI, WC, homocysteine, triglycerides, TNF-α, hs-CRP and lower folate levels when compared to controls. We found 10 proteins whose relative abundances were statistically different between control group and lupus clusters with the best (LCBMP) and the worst metabolic profile (LCWMP). A significant positive correlation was found between TNF-α and triglycerides and between hs-CRP and duration of corticosteroid therapy.
Cardiovascular disease (CVD) risk parameters were worse in c-SLE. A less protective CVD proteomic profile was found in LCWMP.
Knight JS, Kaplan MJ. Cardiovascular disease in lupus: insights and updates. Curr Opin Rheumatol. 2013;25:597–605. [cited 2015 Feb 8] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964608/.
Barsalou J, Bradley TJ, Silverman ED. cardiovascular risk in pediatric-onset rheumatological diseases. Arthritis Res Ther. 2013;15:212. [cited 2015 Mar 9] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672705/.
Hersh AO, von Scheven E, Yazdany J, Panopalis P, Trupin L, Julian L, et al. Differences in long-term disease activity and treatment of adult patients with childhood- and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2009;61:13–20. [cited 2017 Apr 5] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875186/.
Ortiz TT, Terreri MT, Caetano M, Souza FS, D’Almeida V, Sarni ROS, et al. Dyslipidemia in pediatric systemic lupus erythematosus: the relationship with disease activity and plasma homocysteine and cysteine concentrations. Ann Nutr Metab Switzerland. 2013;63:77–82. CrossRef
Moroni G, Novembrino C, Quaglini S, De Giuseppe R, Gallelli B, Uva V, et al. Oxidative stress and homocysteine metabolism in patients with lupus nephritis. Lupus. 2010;19:65–72. [cited 2014 Sep 1] Available from: http://www.ncbi.nlm.nih.gov/pubmed/19933721.
Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J. Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol. 2011;27:174–82. [cited 2014 Aug 22] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21459266.
Ardoin SP, Sandborg C, Schanberg LE. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus. 2007;16:618–26. [cited 2014 Sep 1] Available from: http://www.ncbi.nlm.nih.gov/pubmed/17711898.
Arriens C, Mohan C. Systemic lupus erythematosus diagnostics in the “omics” era. Int J Clin Rheumtol. 2013;8:671–87. [cited 2015 Apr 12] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029501/.
Rana A, Minz RW, Aggarwal R, Sharma S, Pasrija N, Anand S, et al. A comparative proteomic study of sera in paediatric systemic lupus erythematosus patients and in healthy controls using MALDI-TOF-TOF and LC MS-A pilot study. Pediatr Rheumatol. 2012;10:24.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. UNITED STATES; 1997. p. 1725. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9324032.
Schlesselman J. Case-control studies: design, conduct, analysis. 1st ed. New York: Press OU; 1982.
Heymsfield SB, Tighe A, Wang ZM. Nutritional assessment by anthropometric and biochemical methods. In: Shils ME, Olson JASM, editors. Mod. Nutr. Helath Dis. 2nd ed. Malvern: Lea Febiger; 1994. p. 812–41.
Heyward VHSL. Body composition and children. Apllied body compos. Assess. New York: Kinetics H; 1996. p. 91–8.
Posner BM, Borman CL, Morgan JL, Borden WS, Ohls JC. The validity of a telephone-administered 24-hour dietary recall methodology. Am J Clin Nutr. 1982;36:546–53. [cited 2014 Aug 18] Available from: http://www.ncbi.nlm.nih.gov/pubmed/6180624.
Monteiro J. Consumo Alimentar - visualizando porções. Rio de Janeiro: Guanabara Koogan; 2007.
Tanner J. Growth at adolescence: with a general condition of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity. 2nd ed. Oxford: Blackwell Scientific; 1962.
Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288–91. [cited 2017 Aug 30] Available from: http://www.ncbi.nlm.nih.gov/pubmed/11838846.
Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the systemic lupus international collaborating clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996;39:363–9. [cited 2017 Aug 30] Available from: http://www.ncbi.nlm.nih.gov/pubmed/8607884.
Fu Q, Garnham CP, Elliott ST, Bovenkamp DE, Van Eyk JE. A robust, streamlined, and reproducible method for proteomic analysis of serum by delipidation, albumin and IgG depletion, and two-dimensional gel electrophoresis. Proteomics. 2005;5:2656–64. [cited 2015 Mar 12] Available from: http://www.ncbi.nlm.nih.gov/pubmed/15924293.
Cole RN, Ruczinski I, Schulze K, Christian P, Herbrich S, Wu L, et al. The plasma proteome identifies expected and novel proteins correlated with micronutrient status in undernourished Nepalese children. J Nutr. 2013;143:1540–8. [cited 2017 Dec 14] Available from: www.ncbi.nlm.nih.gov/pubmed/23966331.
do Prado R, D’Almeida VM, Guerra-Shinohara E, Galdieri LC, Terreri MT, Hilário MO. Increased concentration of plasma homocysteine in children with systemic lupus erythematosus. Clin Exp Rheumatol. 2006;24:594–8. [cited 2015 Mar 15] Available from: www.ncbi.nlm.nih.gov/pubmed/17181933.
Klack K, Bonfa E, Borba Neto EF. Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol. 2012;52:384–408. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22641593 CrossRefPubMed
de Miranda Moura dos Santos F, Borges MC, Telles RW, Correia MITD, Lanna CCD. Excess weight and associated risk factors in patients with systemic lupus erythematosus. Rheumatol Int. 2013;33:681–8. [cited 2017 Apr 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/22527136.
Sinicato NA, Peres FA, de Oliveira Peliçari K, de Oliveira Santos A, Ramos CD, Marini R, et al. Comparison of estimates of body fat content in childhood-onset systemic lupus erythematosus. Lupus. 2016;26:417–25. [cited 2017 Apr 5] Available from: https://www.ncbi.nlm.nih.gov/pubmed/27872396.
Rizk A, Gheita TA, Nassef S, Abdallah A. The impact of obesity in systemic lupus erythematosus on disease parameters, quality of life, functional capacity and the risk of atherosclerosis. Int J Rheum Dis. 2012;15:261–7. [cited 2015 Mar 17] Available from: http://www.ncbi.nlm.nih.gov/pubmed/22212605.
Padjas A, Undas A, Swadzba J, Musiał J. Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus. Pol Arch Med Wewn. 2007;117:20–5. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17718048.
Von Feldt JM, Scalzi LV, Cucchiara AJ, Morthala S, Kealey C, Flagg SD, et al. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. Arthritis Rheum. 2006;54:2220–7. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16802358.
Tso TK, Huang H-Y, Chang C-K, Huang W-N. A positive correlation between homocysteine and brachial-ankle pulse wave velocity in patients with systemic lupus erythematosus. Clin Rheumatol. 2006;25:285–90. [cited 2017 Apr 5] Available from: https://www.ncbi.nlm.nih.gov/pubmed/16429235.
Refai TMK, Al-Salem IH, Nkansa-Dwamena D, Al-Salem MH. Hyperhomocysteinaemia and risk of thrombosis in systemic lupus erythematosus patients. Clin Rheumatol. 2002;21:457–61. [cited 2014 Sep 4] Available from: https://www.ncbi.nlm.nih.gov/pubmed/12447627.
Rho YH, Oeser A, Chung CP, Morrow JD, Stein CM. Drugs to treat systemic lupus Erythematosus: relationship between current use and cardiovascular risk factors. Arch Drug Inf. 2008;1:23–28. [cited 2014 Sep 2] Available from: https://www.ncbi.nlm.nih.gov/pubmed/20157365.
Mirhafez SR, Tajfard M, Avan A, Pasdar A, Nedaeinia R, Aghasizade M, et al. Association between serum cytokine concentrations and the presence of hypertriglyceridemia. Clin Biochem. 2016;49:750–5. [cited 2017 Dec 14] Available from: https://www.ncbi.nlm.nih.gov/pubmed/27048855.
Balanescu S, Calmac L, Constantinescu D, Marinescu M, Onut R, Dorobantu M. Systemic inflammation and early atheroma formation: are they related? Maedica (Buchar). 2010;5:292–301. [cited 2017 Apr 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21977173.
Sozeri B, Deveci M, Dincel N, Mir S. The early cardiovascular changes in pediatric patients with systemic lupus erythematosus. Pediatr Nephrol. 2013;28:471–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23135607. CrossRefPubMed
Ardoin SP, Schanberg LE, Sandborg C, Yow E, Barnhart HX, Mieszkalski KL, et al. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010;19:1315–25. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20861207.
Wang K-C, Liu P-H, Yu K-H, Weng Y-M, Ng C-J, Chiu T-F, et al. Is initial C-reactive protein level associated with corticosteroid use in lupus erythematosus patients during a bacterial infection episode? Immunol Lett. 2017;185:84–9. [cited 2017 Dec 14] Available from: https://www.ncbi.nlm.nih.gov/pubmed/28286229.
Machado D, Sarni ROS, Abad TTO, Silva SGL, Khazaal EJB, Hix S, et al. Lipid profile among girls with systemic lupus erythematosus. Rheumatol Int. 2017;37:43–8. [cited 2017 Apr 5] Available from: http://www.ncbi.nlm.nih.gov/pubmed/26573664.
Getz GS, Reardon CA. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall. J Lipid Res. 2009;50(Suppl):S156-61. [cited 2015 Sep 3] Available from: https://www.ncbi.nlm.nih.gov/pubmed/19018038.
Sottrup-Jensen L. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem. 1989;264:11539–42. [cited 2015 Apr 7] Available from: http://www.ncbi.nlm.nih.gov/pubmed/2473064.
Alpha-1-antichymotrypsin - alpha-1-antichymotrypsin/ ACT - Homo sapiens (Human). [cited 2014 Aug 21]. Available from: http://www.uniprot.org/uniprot/Q15965.
Ceruloplasmin precursor - CP - Homo sapiens (Human). [cited 2014 Aug 22]. Available from: http://www.uniprot.org/uniprot/P00450.
Serotransferrin precursor - TF - Homo sapiens (Human). [cited 2014 Aug 22]. Available from: http://www.uniprot.org/uniprot/P02787.
Haptoglobin precursor - HP - Homo sapiens (Human). [cited 2014 Aug 22]. Available from: http://www.uniprot.org/uniprot/P00738.
Tolosano E, Altruda F. Hemopexin: structure, function, and regulation. DNA Cell Biol. 2002;21:297–306. [cited 2015 Apr 7] Available from: http://www.ncbi.nlm.nih.gov/pubmed/12042069.
Kaur P, Rizk NM, Ibrahim S, Younes N, Uppal A, Dennis K, et al. iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. J Proteome Res. 2012;11:5527–39. [cited 2017 Nov 14] Available from: http://pubs.acs.org/doi/abs/10.1021/pr300798z.
Karp NA, Lilley KS. Investigating sample pooling strategies for DIGE experiments to address biological variability. Proteomics. 2009;9:388–97. [cited 2017 Nov 14] Available from: https://www.ncbi.nlm.nih.gov/pubmed/19105178.
- Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?
Roberta Garcia Salomão
Luciana Martins de Carvalho
Érika Silva Czernisz
José César Rosa
Sonir Roberto Rauber Antonini
Ana Carolina Bueno
Maria Olímpia Ribeiro do Vale Almada
Carolina de Almeida Coelho-Landell
Alceu Afonso Jordão
Virgínia Paes Leme Ferriani
Jacqueline Pontes Monteiro
- BioMed Central